Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
Palleria C, Iannone L, Leporini C, Citraro R, Manti A, Caminiti M, Gigliotti P, Grembiale RD, L'Andolina M, Muccari G, Naturale MD, Olivo D, Pagano Mariano G, Pellegrini R, Varcasia G, Abdalla K, Russo E, Ursini F, De Sarro G.
Palleria C, et al. Among authors: grembiale rd.
PLoS One. 2018 Oct 24;13(10):e0205134. doi: 10.1371/journal.pone.0205134. eCollection 2018.
PLoS One. 2018.
PMID: 30356301
Free PMC article.